Gusterson B - Search Results

1

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Among authors: gusterson b. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

2

Ser392 phosphorylation regulates the oncogenic function of mutant p53.

Yap DB, Hsieh JK, Zhong S, Heath V, Gusterson B, Crook T, Lu X. Yap DB, et al. Among authors: gusterson b. Cancer Res. 2004 Jul 15;64(14):4749-54. doi: 10.1158/0008-5472.CAN-1305-2. Cancer Res. 2004. PMID: 15256442

3

Concomitant inactivation of p53 and Chk2 in breast cancer.

Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T. Sullivan A, et al. Among authors: gusterson ba. Oncogene. 2002 Feb 21;21(9):1316-24. doi: 10.1038/sj.onc.1205207. Oncogene. 2002. PMID: 11857075

4

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ, Tavassoli M, Gusterson B, Crook T. Gasco M, et al. Among authors: gusterson b. Cancer Res. 2002 Apr 1;62(7):2072-6. Cancer Res. 2002. PMID: 11929827

5

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer.

Gusterson BA, Ross DT, Heath VJ, Stein T. Gusterson BA, et al. Breast Cancer Res. 2005;7(4):143-8. doi: 10.1186/bcr1041. Epub 2005 May 5. Breast Cancer Res. 2005. PMID: 15987465 Free PMC article. Review.

6

Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.

Stein T, Price KN, Morris JS, Heath VJ, Ferrier RK, Bell AK, Pringle MA, Villadsen R, Petersen OW, Sauter G, Bryson G, Mallon EA, Gusterson BA. Stein T, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6872-9. doi: 10.1158/1078-0432.CCR-05-0547. Clin Cancer Res. 2005. PMID: 16203777

7

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T. Gasco M, et al. Among authors: gusterson b. Oncogene. 2002 Mar 14;21(12):1876-81. doi: 10.1038/sj.onc.1205256. Oncogene. 2002. PMID: 11896620

8

Distinct genetic and epigenetic changes in medullary breast cancer.

Osin P, Lu YJ, Stone J, Crook T, Houlston RS, Gasco M, Gusterson BA, Shipley J. Osin P, et al. Among authors: gusterson ba. Int J Surg Pathol. 2003 Jul;11(3):153-8. doi: 10.1177/106689690301100301. Int J Surg Pathol. 2003. PMID: 12894346

9

TSC-22D1 isoforms have opposing roles in mammary epithelial cell survival.

Huser CA, Pringle MA, Heath VJ, Bell AK, Kendrick H, Smalley MJ, Crighton D, Ryan KM, Gusterson BA, Stein T. Huser CA, et al. Among authors: gusterson ba. Cell Death Differ. 2010 Feb;17(2):304-15. doi: 10.1038/cdd.2009.126. Epub 2009 Sep 11. Cell Death Differ. 2010. PMID: 19745830

10

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours.

Crook T, Brooks LA, Crossland S, Osin P, Barker KT, Waller J, Philp E, Smith PD, Yulug I, Peto J, Parker G, Allday MJ, Crompton MR, Gusterson BA. Crook T, et al. Among authors: gusterson ba. Oncogene. 1998 Oct 1;17(13):1681-9. doi: 10.1038/sj.onc.1202106. Oncogene. 1998. PMID: 9796697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters